NIRAPARIB WITH ABIRATERONE ACETATE AND PREDNISONE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE PHASE 2 QUEST STUDY

被引：0
|
作者：
Chi, Kim
Fleshner, Neil
Chiuri, Vincenzo Emanuele
Van Bruwaene, Siska
Hafron, Jason
McNeel, Douglas G.
De Porre, Peter
Maul, R. Scott
Daksh, Mahesh
Zhong, Xiaogang
Mason, Gary E.
Tutrone, Ronald
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP27-17
引用
收藏
页码：E456 / E457
页数：2
相关论文
共 50 条
  • [21] Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone
    Yang, Zhenyu
    Ni, Yuchao
    Zhao, Diwei
    Zhang, Yijun
    Wang, Jun
    Jiang, Lijuan
    Chen, Dong
    Wu, Zhiming
    Wang, Yanjun
    He, Liru
    Shi, Yanxia
    Zhou, Fangjian
    Zeng, Hao
    Li, Yonghong
    BMC CANCER, 2021, 21 (01)
  • [22] Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone
    Zhenyu Yang
    Yuchao Ni
    Diwei Zhao
    Yijun Zhang
    Jun Wang
    Lijuan Jiang
    Dong Chen
    Zhiming Wu
    Yanjun Wang
    Liru He
    Yanxia Shi
    Fangjian Zhou
    Hao Zeng
    Yonghong Li
    BMC Cancer, 21
  • [23] A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer
    McKay, Rana R.
    Werner, Lillian
    Jacobus, Susanna J.
    Jones, Xandra
    Mostaghel, Elahe A.
    Marck, Brett T.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Sweeney, Christopher J.
    Slovin, Susan F.
    Morris, Michael J.
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    CANCER, 2019, 125 (04) : 524 - 532
  • [24] Phase I trial of apalutamide plus abiraterone acetate, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Molina, Ana
    Christos, Paul
    Hackett, Amy
    Nordquist, Luke
    Gelmann, Edward
    Stein, Mark
    Sternberg, Cora
    Beltran, Himisha
    Gracey, Lauren
    Galletti, Giuseppe
    Giannakakou, Paraskevi
    Nanus, David M.
    Tagawa, Scott T.
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer
    K. N. Chi
    A. Tolcher
    P. Lee
    P. J. Rosen
    C. K. Kollmannsberger
    K. P. Papadopoulos
    A. Patnaik
    A. Molina
    J. Jiao
    C. Pankras
    B. Kaiser
    A. Bernard
    N. Tran
    M. Acharya
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 237 - 244
  • [26] Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer
    Chi, K. N.
    Tolcher, A.
    Lee, P.
    Rosen, P. J.
    Kollmannsberger, C. K.
    Papadopoulos, K. P.
    Patnaik, A.
    Molina, A.
    Jiao, J.
    Pankras, C.
    Kaiser, B.
    Bernard, A.
    Tran, N.
    Acharya, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 237 - 244
  • [27] Treatment of Metastatic Castration-resistant Prostate Cancer Patients With Abiraterone Acetate and Prednisone and Corresponding Survival Prognostic Factors
    Romero, Miguel E. jimenez
    Gallego, Maria Camacho
    Serrato, Jose c. navarro
    Sanchez Hurtado, Miguel A.
    Santotoribio, Jose D.
    ANTICANCER RESEARCH, 2021, 41 (08) : 3955 - 3968
  • [28] The economics of abiraterone acetate for castration-resistant prostate cancer
    Dellis, Athanasios
    Papatsoris, Athanasios G.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (02) : 175 - 179
  • [29] Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
    Salem, Mohamed
    Garcia, Jorge A.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (02) : 92 - 96
  • [30] PHASE 3 MAGNITUDE STUDY: RESULTS FROM SECOND INTERIM ANALYSIS OF NIRAPARIB WITH ABIRATERONE ACETATE AND PREDNISONE AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH AND WITHOUT HRR GENE ALTERATIONS
    Rathkopf, Dana E.
    Small, Eric
    Guckert, Mary
    Chi, Kim N.
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
12345